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Abstract
Background: Previous studies indicated that oral squamous cell carcinomas (OSCC) might be related to human papilloma
virus (HPV) infection. However, up to now, there still lacks a large sample study to analyze the relationship between OSCC in
a Chinese population and oral HPV infection. In the present study, we used a meta-analysis to evaluate the relationship of
OSCC with HPV infection in a Chinese population.
Methods: The reports on HPV and OSCC in a Chinese population published between January, 1994, and September, 2011
were retrieved via CNKI/WANFANG/OVID/MEDLINE databases. According to the inclusion criteria, we selected 18 eligible
case-control studies. After testing the heterogeneity of the studies by the Cochran Q test, the meta-analyses for HPV and
HPV16 were performed using the fixed effects model.
Results: The overall positive rates of HPV and HPV16 in OSCC were 58.0% (354/610; 95% confidence interval [CI], 54.1–61.9)
and 47.47% (169/356; 95% CI: 42.3–52.7), respectively; which were significantly higher than those in normal controls 10.44%
(26/249; 95% CI: 7.2–14.7) and 7.1% (13/182; 95% CI: 4.2–11.8). Quantitative meta-analysis revealed that, compared with
normal controls, the combined odds ratios of OSCC with HPV or HPV16 infection were 12.7 (95% CI: 8.0–20.0) and 9.0 (95%
CI: 5.1–15.6), respectively. Both Begg’s test and funnel plots revealed that no publication bias was found in this present
study (P.0.05).
Conclusions: High incidences of HPV infection (mainly involving HPV16) were found in the samples of Chinese OSCC. For
the Chinese population, HPV infection elevates the risk of OSCC tumorigenesis. Prophylactic HPV-vaccination may reduce
the burden of HPV-related OSCC in China.
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Introduction
As a member of the papillomavirus family of viruses, human
papillomavirus (HPV) can infect humans by attacking the
squamous cell of skin and mucous membranes. Based on the
different nucleotide sequences, HPV can be divided into more
than 200 genotypes by DNA sequencing, and 85 HPV genotypes
have been well characterized [1], of which HPV16 and HPV18 as
main high-risk types are more closely linked with malignant
tumors [2]. In fact, HPV infection is a cause of nearly all cases of
cervical cancer. Over 90% of all cervical cancers can be attributed
to certain HPV types-HPV16 accounting for the largest pro-
portion (roughly 50%) followed by HPV18 (12%), HPV 45 (8%),
and HPV 31 (5%) [3]. Worldwide in 2002, an estimated 561,200
new cancer cases (5.2% of all new cancers) were attributable to
HPV, suggesting that HPV is one of the most important infectious
causes of cancer [4]. Cancers of the head and neck are usually
caused by tobacco and alcohol, but recent studies show that about
25% of mouth and 35% of throat cancers in the United States of
America are caused by HPV. Recent increases in incidence of
oropharyngeal cancers in the USA have been attributed to HPV
infection [5,6]. In recent years, some studies by Chinese
researchers have also focused on the relationship between oral
squamous cell carcinoma (OSCC) and HPV oral infection.
However, the differences of the odds rates were reported in
different literatures. Therefore, it is necessary to implement a meta-
analysis which aims to comprehensively evaluate the relationship
between OSCC and HPV oral infection in a Chinese population.
Methods
Search Strategy
The keywords HPV, human papillomavirus, oral, oral cancer,
head and neck cancer, tongue cancer, squamous cell carcinoma,
oral carcinoma, buccal cancer, oral lesions, and Chinese
population and China in address in Chinese language or in
English language were used alone and in combination to search.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36294The retrieved databases included China National Knowledge
Infrastructure (CNKI)/Wanfang Database/OVID/MEDLINE.
Finally, a total of 361 citations published between Jun, 1994 and
Oct, 2011 were identified.
Inclusion and Exclusion Criteria
The literatures included in the present study meets the following
criteria: case-control studies; the participants belong to a Chinese
population; a clear description of diagnostic methods was needed
and the detection methods were reliable. The literatures excluded
in this study were mainly due to the following reasons: lacks
normal control group; reviews; the literatures include the repeated
data; the research design isn’t scientific and reasonable. Study
identification and selection is elaborated in the flow diagram
(Figure 1). Of 361 publications identified through an initial search
of databases and conference abstracts, 343 were excluded for
reasons explained in Figure 1. A total of 18 literatures met the
eligibility criteria were included in this present study.
Data Extraction
The data related to this study were extracted by two
independent reviewers (ZCT and LY) based on a standardized
data extraction program designed in advance. Any discrepancies
were resolved by consensus or in consultation with a third reviewer
(DCL). The data related to this study were shown in Table 1 and
Table 2.
Data Analysis Data
The dichotomous data of HPV or HPV16 positive results in
OSCC group and normal control group was summarized. OR and
95% confidence interval [CI] of OR were calculated for assessing
the association between HPV or HPV16 infection and OSCC risk.
Figure 1. Flow diagram of the selection for the studies included
in this meta-analysis.
doi:10.1371/journal.pone.0036294.g001
Table 1. Characteristics of studies investigating human
papillomavirus (HPV) infection in oral squamous cell
carcinoma (OSCC) and control samples.
Year Authors Method OSCC Controls
Pos Neg Pos Neg
1 1994 T Zhang et al PCR 4 2 0 10
2 1996 YL Li et al PCR 20 6 3 12
3 1996 L Lei et al PCR 4 3 2 6
4 1998 WT Gao et al PCR 30 10 4 36
5 1998 ZJ Tao et al PCR 14 4 3 27
6 1998 WL Chen et al PCR 11 10 3 18
7 2000 W Hou et al Dot blot
hybridization
16 16 0 10
8 2000 JQ Bu et al PCR 29 21 0 5
9 2001 ZQ Lin et al PCR 28 38 1 11
10 2004 C Yang et al Hybridization
in situ
14 16 0 20
11 2004 P Zhou et al Hybridization
in situ
17 16 0 8
12 2004 H Zheng et al PCR 13 7 2 14
13 2005 LL Zhong et al PCR 56 10 2 10
14 2006 QY Wei et al Dot blot
hybridization
19 18 4 17
15 2006 XF Tang et al Hybridization
in situ
20 10 0 5
16 2008 AE He et al PCR 5 11 0 4
17 2011 LZ Li et al PCR 24 32 1 11
18 2011 L Cheng et al Hybridization
in situ
30 26 1 9
Pos: Positive; Neg: Negative.
doi:10.1371/journal.pone.0036294.t001
Table 2. Characteristics of studies investigating human
papillomavirus (HPV) 16 infection in oral squamous cell
carcinoma (OSCC) and control samples.
Year Authors Method OSCC Controls
Pos Neg Pos Neg
1994 T Zhang et al PCR 4 2 0 10
1996 L Lei et al PCR 8 15 2 6
1998 WT Gao et al PCR 29 11 1 39
1998 WL Chen et al PCR 11 10 3 18
1998 ZJ Tao et al PCR 12 6 0 30
2000 JQ Bu et al PCR 23 27 0 5
2000 W Hou et al dot blot
hybridization
16 16 0 10
2001 ZQ Lin et al PCR 28 38 1 11
2004 H Zheng et al PCR 10 10 2 14
2006 QY Wei et al dot blot
hybridization
13 21 4 17
2006 XF Tang et al PCR 10 20 0 5
2008 AE He et al PCR 5 11 0 4
Pos: Positive; Neg: Negative.
doi:10.1371/journal.pone.0036294.t002
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using the Chi-square-based Q test [7]. A P value less than 0.05 was
considered significant for the heterogeneity. If no heterogeneity,
a fixed-effect model was applied using the Mantel-Haenszel
method [8]. Otherwise, the random-effect model with the
DerSimonian-Laird method [8] was used. The potential publica-
tion bias was assessed graphically by Begg’s test and analysis for
funnel plots [9]. The statistical analyses were performed using
RevMan 4.2 and Stata 10.0.
Results
The overall positive rates of HPV and HPV16 in OSCC were
58.0% (354/610; 95% CI: 54.1–61.89) and 47.5% (169/356; 95%
CI: 42.3–52.7), respectively; which were significantly higher than
those in normal controls 10.4% (26/249; 95% CI: 7.2–14.9) and
7.1% (13/182; 95% CI: 4.2–11.8).Tests for the heterogeneity
showed that, the Chi-square values for HPV and HPV16 were
9.98 and 14.82, respectively (P,0.05). Therefore, a fixed-effect
model was applied. Quantitative meta-analyses showed that,
compared with normal oral mucosa the combined odds ratio of
OSCC with HPV and HPV16 infection were 12.7 (95% CI: 8.0–
20.0) and 8.95 (95% CI: 5.1–15.6), respectively. The test for
overall effect showed that the P value was less than 0.00001
(Z=10.9). Forest plot analyses were seen in Figure 2 and Figure 3.
Publication bias analysis using RevMan 4.2 software funnel plot of
included studies were measured indicators of the graphics of the
basic symmetry, all points is concentrated in the central funnel
(Figure 4, 5). Begg’s test (using Stata 10.0) showed that there had
no publication bias (P.0.05).
Discussion
Oral cancer belongs to head and neck cancer is any cancerous
tissue growth located in the oral cavity. There are several types of
oral cancers, 90% of which are OSCC and followed by glandular
epithelial carcinoma (mucoepidermoid carcinoma, adenocarcino-
ma, adenoid cystic carcinoma, malignant pleomorphic adenoma,
and acinar cell carcinoma) and undifferentiated carcinoma. Oral
or mouth cancer most commonly involves the tongue. However,
the tumorigenesis of OSCC is complicated. Smoking and other
tobacco use are associated with about 75 percent of oral cancer
cases [10]. Both alcohol use and chewing betel nut were also
reported to be high-risk factors associated with tumorigenesis of
oral cancer [11,12,13,14,15]. Patients after hematopoietic stem
cell transplantation (HSCT) are at a higher risk for tumorigenesis
of OSCC [16]. In addition, HPV, in particular type 16, have been
found to be associated with oropharyngeal cancer
[17,18,19,20,21]. The previous study confirmed that oral infection
with HPV increased the risk of tumorigenesis of oropharyngeal
cancer independent of tobacco use [22]. Sexually-transmitted
HPVs also cause most of anal cancers and approximately 25% of
oropharynx cancers [4]. Engaging in anal sex or oral sex with an
HPV-infected partner may increase the risk of developing these
types of cancers [17]. HPV is estimated to be the most common
sexually transmitted infection in the United States [23]. Along with
the elevation of HPV incidence, the incidence of oropharyngeal
cancers in the United States had increased between 1973 and
2007, whereas that of cancers at other head and neck sites has
decreased steadily [24]. The evidences revealed that the odds ratio
of oral HPV infection increases with the number of recent oral sex
Figure 2. Forest plot of human papillomavirus prevalence in oral squamous cell carcinoma and control samples. OSCC: oral squamous
cell carcinoma.
doi:10.1371/journal.pone.0036294.g002
Relationship between OSCC and HPV
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36294partners or open-mouthed kissing partners [25] and nonsexual
oral infection through salivary or cross transmission is also
plausible [26].
There have some elucidated mechanisms of tumorigenesis of
OSCC related to HPV infection. HPV viral sequences can
integrate into the cellular DNA and the HPV ‘‘early’’ genes such
as E6 and E7 can be expressed by host cells and then promote
malignant transformation. In addition, E6 has a close relationship
with the cellular E6-associated protein, which is involved in the
degradation of p53 protein (a tumor suppressor factor can prevent
cell growth and stimulates apoptosis in the presence of DNA
damage), thereby cause tumors. In vitro studies suggested that the
E6 protein of the HPV types implicated may inhibit apoptosis
induced by ultraviolet light [27]. Many studies confirmed that
Figure 3. Forest plot of human papillomavirus 16 prevalence in oral squamous cell carcinoma and control samples. OSCC: oral
squamous cell carcinoma.
doi:10.1371/journal.pone.0036294.g003
Figure 4. Funnel plot of the included studies of oral squamous cell carcinoma risk in HPV infection.
doi:10.1371/journal.pone.0036294.g004
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cancer, as well as anal cancer, vulvar cancer, vaginal cancer, and
penile cancer [4].
In 1983, OSCC was firstly reported to be associated with HPV
infection [28]. Afterwards, many studies showed that a different
degree of relationship might exist between OSCC and HPV
infection. It is possible that the risk difference of OSCC with HPV
infection varies from different regions and different populations.
An alternative to HPV DNA testing is more specific novel
biomarkers as HPV E6/E7 mRNA measuring the interaction of
HPV with human cells [6,29,30,31,32]. In the study, we aimed to
evaluate the relationship between OSCC and HPV infection in
a Chinese population. Eighteen eligible case control studies
showed that, HPV and HPV16 positive rates in normal oral
mucosa ranged from 0–20% and 0–19.05%, respectively; while in
OSCC were between 31.3%–84.9% and between 31.3%–72.5%,
respectively. Based on the statistical results, the overall positive
rates of detecting HPV and HPV16 in OSCC were 58.0% and
47.5%, respectively; which were significantly higher than those in
normal controls 10.4% and 7.1%. Therefore, we believed that
high infection incidences of HPV (mainly involving HPV16) were
found in the samples of OSCC of a Chinese population. The
recently published meta-analysis (1988–2007) [33] investigating
HPV infection in OSCC and head and neck squamous cell
carcinoma showed that the pooled prevalence of HPV DNA in the
overall samples was 34.5%, and in OSCC was 38.1%. In
comparison with the data, the overall incidences of HPV in this
present meta-analysis were significantly higher (58.0% vs 38.1%,
P,0.01).
The quantitative meta-analysis showed that, compared with
normal oral mucosa, the pooled odds ratios of OSCC with HPV
and HPV16 infection were 12.7 (95% CI: 8.0–20.0) and 9.0 (95%
CI: 5.1–15.6), respectively. While another previous meta-analysis
of the included literatures published in English-language journal
between 1980 and 1998 revealed that [34], the likelihood of
detecting HPV in normal oral mucosa (10.0%; 95% [CI], 6.1%–
14.6%) was significantly less than that of OSCC (46.5%; 95% CI:
37.6%–55.5%), and the pooled odds ratio for the subset of studies
directly comparing the prevalence of HPV in normal mucosa and
OSCC was 5.4. Compared with the reported data, the pooled
odds ratios of OSCC vs normal controls in this meta-analysis were
higher significantly, suggesting that, for a Chinese population,
HPV oral infection could cause a higher risk of tumorigenesis of
OSCC.
The funnel plots of included studies showed that, the graphics is
basically symmetric and all points is concentrated in the central
funnel, indicating that no publication bias was found in this study.
As a result, we believed that higher HPV infection incidences were
found in the samples of OSCC of a Chinese population; HPV
infection, mainly related to HPV16, elevates the risk of OSCC
tumorigenesis. Therefore, HPV vaccines might also be a potential
value in the prevention of OSCC. It is reported that, the HPV
vaccines, which prevent infection with the HPV16/18 that cause
70% of cervical cancer, may lead to further decrease [35,36]. Up
to now, the definite effectiveness of the HPV vaccine in preventing
OSCC has kept unknown.
However, the previous reports showed that the patients with
HPV-positive oropharyngeal cancers had a lower risk of dying or
recurrence than do those with HPV-negative cancers [37,38,39].
The majority of studies showed than HPV-associated OSCC were
associated with a better prognosis than HPV-negative tumors in
the majority of studies [40,41,42,43,44]. In the prior study, HPV-
positive conferred a 60% to 80% reduction in risk of death from
cancer compared with HPV-negative tumors [45]. So, screening
for HPV in the patients with OSCC is also significant for assessing
the prognosis of OSCC. Prophylactic HPV-vaccination may
reduce the burden of HPV-related OSCC in China.
However, this meta-analysis may have two potential limitations.
Firstly, most of the literatures included the present study didn’t
consider the potentially interfering factors, such as gender, age,
socio-economic conditions, and lifestyle (smoking, chewing betel
nut, and alcohol so on). Especially for lifestyle, some studies have
Figure 5. Funnel plot of the included studies of oral squamous cell carcinoma risk in HPV16 infection.
doi:10.1371/journal.pone.0036294.g005
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OSCC and HPV infection. Besides, although OSCC group were
diagnosed by pathological check, but lacked the subgroup analysis
such as tumor location, clinical stage as well as degree of
differentiation and so on. Considering that HPV infection plays an
important role in tumorigenesis of OSCC, more scientific studies
are worthwhile to do in the future.
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